| Literature DB >> 30149127 |
Esmaeil Salimi1, Bao Le-Vinh2, Forouhe Zahir-Jouzdani3, Barbara Matuszczak4, Azadeh Ghaee5, Andreas Bernkop-Schnürch6.
Abstract
To overcome the mucus layer and cell membrane barrier, self-emulsifying drug delivery systems (SEDDS) exhibiting negative zeta potential, switching to positive values when having reached the cell membrane is a promising approach. Accordingly, a novel conjugate was synthesized by covalent attachment of phosphotyrosine to octadecylamine, which was incorporated into SEDDS. Generated system presented an average diameter of 32 nm and zeta potential of around -12 mV when being diluted 1:100 in 100 mM HEPES buffer pH 7.5 containing 5 mM MgCl2 and 0.2 mM ZnCl2. Incubation of SEDDS with isolated intestinal alkaline phosphatase (IAP) resulting in enzymatic cleavage of phosphate ester moiety caused a shift in zeta potential up to +5.3 mV. As non-toxicity of the developed SEDDS diluted 1:1000 in 25 mM HEPES buffer pH 7.5 containing 5% glucose was observed on Caco-2 cells by employing resazurin assay, this system may provide an inspiring strategy for future zeta potential changing drug delivery systems to master the mucus and membrane barrier.Entities:
Keywords: Intestinal alkaline phosphatase; Mucus barrier; Self-emulsifying drug delivery systems; Zeta potential changing systems
Mesh:
Substances:
Year: 2018 PMID: 30149127 DOI: 10.1016/j.ijpharm.2018.08.046
Source DB: PubMed Journal: Int J Pharm ISSN: 0378-5173 Impact factor: 5.875